Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis

Archives of Disease in Childhood

Volumn 76, Issue 5, 1997, Pages 437-440

  Vic, P ^a   Ategbo, S ^a   Gottrand, F ^a   Launay, V ^a   Loeuille, G A ^b   Elian, J C ^c   Druon, D ^c   Farriaux, J P ^a   Turck, D ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Hospital of Dunkirk   (France)

^c Camiers City Hospital   (France)

Author keywords

Anthropometry; Antibiotics; Bioelectrical analysis; Cystic fibrosis

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTHROPOMETRY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BIOENERGY; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN METABOLISM; PSEUDOMONAS AERUGINOSA; WEIGHT GAIN;

EID: 0030938178     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.76.5.437     Document Type: Article

References (25)

1. Corey M, McLaughlin FJ, Williams M. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:588-93.
2. Steinkamp G, Drommer A, Von der Hardt H. Resting energy expenditure before and after treatment for Pseudomonas aeruginosa infection in patients with cystic fibrosa. Am 3 Clin NUIT 1993;57:685-9.
3. Shepherd RV, Holt TL, Gleghorn G, Ward LC, Isles A, Francis P. Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study, including effect on protein turnover. A m J Clin Nutr 1988;48:235-9.
4. Smith AL, Ramsey B, Redding G, Haas J. Endobronchial infection in cystic fibrosis patients. Acta Paediatr Scand Suppl 1989;363:31-6.
5. Sempe M, Pedron G, Rpy-Pernot MF. In: Théraplix A, éd. Auxologie. Méthodes et séquences. Paris: Printel, 1979.
6. Dupin H, Abraham ], Giachetti I. Apports nutritionneh conseillés pour la population française. 2nd Ed. Paris: Tec and Doc, 1994.
7. Brook CGD. Determination of body composition of children from skinfold measurements. Arch Dis Child 1971 ; 46:182-4.
8. Durnin JVGA, Rahaman MM. The assessment of the amount of fat in the human body from measurement of the skinfold thickness. BrJNutr 1967;21:681-9.
9. Schaefer F, Georgi M, Zieger A, Scharer K. Usefulness of bioelectric impedance and skinfold measurements in predicting fat-free mass derived from total body potassium in children. Pediatr Res 1994;35:617-24.
10. Bland JM, Airman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
11. Borowitz D, Conboy K. Are bioelectrical impedance measurements valid in patients with cystic fibrosis? J Pediatr Gastroenterol Nutr 1994;18:453-6.
12. Spicher V, Roulet M, Schaffner C, Schutz Y. Bio-electrical impedance analysis for estimation of fat-free mass and muscle mass in cystic fibrosis patients. EurJ Pediatr 1993; 152:222-5.
13. Azcue M, Fried M, Pencharz PB. Use of bipelectrical impedance analysis to measure total body water in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1993;16: 440-5.
14. SzaffM, Hoiby N, Flensborg W. Frequent antibiotic therapy improves suraval of cystic fibrosis patients with chronic Pseudomonas aerugïnûsa infection. Acia Pacdiatr Scand 1983;72:651-7.
15. Kraemer R, Rudeberg A, Hadorn B, Rossi E. Relative underweight in cystic fibrosis and its prognosis value. Ada Paediatr Scand 1978;67:33-7.
16. Gaskin KJ. The impact of nutrition in cystic fibrosis: a review. J Pediair Gastromterol Nutr 1988;7(suppl 1):S12-17.
17. Dodge JA. Nutritional requirements in cystic fibrosis: a review. JPediatr Gastroenterol Nutr 1988;7(suppl 1):S8-11.
18. Ramsey BV, Farrell PM, Pencharz P, and the Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am JClin A'HO- 1992;SS: 108-16.
19. Keusch GT. Malnutrition, infection and immune function. In: Suskind RA1, Lewinter-Suskind L, eds. The malnourished child. New York: Raven Press, 1990:37-59.
20. Suter S, Schaad VB, Roux-Lombard P, Girardin E, Grau G, Dayer JM. Relation between tumor necrosis factor-alpha and granulocyte elastase- alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis./lm Rev Respir Dis 1989;140:1640-4.
21. Girardet JP, Tounian P, Sardet A, et al. Resting energy expenditure in infants with cystic fibrosis. J Pediaar GasiroenterolNutr 1994;18:214-9.
22. Bowler IM, Green JH, Wolfe SP, Littlewood JM. Resting energy expenditure and substrate oxidation rates in cystic fibrosis. Arch Dis Child 1993;68:754-9.
23. Grunow JE, Azcue MP, Berrall G, Pencharz PB. Energy expenditure in cystic fibrosis during activity of daily living. JPediatr 1993;122:243-6.
24. Vaisman N, Pencharz PB, Corey M, Canny GJ, Hahn E. Energy expenditure of patients with cystic fibrosis. JPediatr 1987;1I1:496-500.
25. Naon H, Hack S, Shelton MT, Gotthoffer RC, Gozal D. Resting energy expenditure. Evolution during antibiotic treatment for pulmonary exacerbation in cystic fibrosis. Chest 1993;103:1819-25.